The Procter & Gamble Company
Manufactures and sells household and personal care products globally under brands including Tide, Gillette, Pampers, Olay, and Crest.
As of Aug 31, 2026
Summary
The Procter & Gamble Company manufactures and distributes consumer staples including personal care, cleaning, and health products globally. The stock is showing a bearish technical bias despite a modest day gain of 0.4%, with the share price at $143.78 reflecting a one-year decline of 5.7% and a market capitalisation of $335 billion.
Price history
As of Aug 28, 2026
Performance
+0.93%
-0.62%
-0.13%
+0.90%
+2.56%
-5.70%
As of Aug 28, 2026
Technical indicators
- 45.5
- -0.01Bearish
- 50: 146.53 · 200: 145.78
- $143.59 / $144.76
Technical Bias
Bearish lean
Procter & Gamble's technical picture leans bearish, with MACD showing downside momentum whilst RSI and moving averages remain neutral. This is a derived technical read, not a recommendation.
A transparent read of the indicators below — not a prediction or recommendation.
As of Aug 28, 2026
Fundamentals
- $335B
- 21.65
- $6.64
- 18.44%
- +1.5%
- $15.9B
- 0.38
- $134.62 – $164.77
- 3.04%
- Jul 24, 2026
- —
As of Aug 31, 2026
Latest news
As of Aug 31, 2026
MonkeyTrade's Take on The Procter & Gamble Company
Short-term outlook
The short-term technical read on P&G leans mildly bearish rather than decisive, with MACD in negative territory even as RSI sits neutral and the stock hugs its flat 50- and 200-day averages. A move through $144.76 resistance would ease the pressure, while a break below $143.59 support would confirm the softer tone. No earnings date is set, so the next few weeks look driven more by this narrow range than any scheduled catalyst.
Medium-term outlook
Procter & Gamble's fundamentals look steady rather than exciting: 1.5% revenue growth and an 18.4% profit margin support a resilient, cash-generative business paying a 3.0% dividend, but a 21.65 P/E leaves little room for error when growth is this modest. With the technical lean bearish, the medium-term picture skews toward consolidation or softness. A meaningful pickup in revenue growth would be the trigger to revisit that view.
Key risks
- Revenue growth of just +1.5% year over year points to a business that is expanding slowly, which could limit upside if input costs or competition pressure margins.
- The stock is trading near the lower half of its 52-week range ($143.78 against a $134.62–$164.77 band), suggesting recent underperformance that may reflect broader sentiment concerns.
- As a large, established consumer staples name, P&G carries a low beta of 0.38, meaning it moves less than the market, but this also means it may lag during strong market rallies.
- News coverage questioning whether the stock is underperforming the Nasdaq highlights the risk that investors chasing growth may continue to favour other sectors over defensive names like this one.
About The Procter & Gamble Company
Procter & Gamble is a US consumer defensive giant listed on the NYSE under the ticker PG, operating in the household and personal products industry. With a market capitalisation of $335 billion, it ranks among the largest companies in its sector, reflecting its broad reach across everyday household and personal care goods that consumers tend to keep buying regardless of economic conditions.
P&G's price-to-earnings ratio of 21.65 shows how much investors are currently willing to pay for each dollar of its earnings, a figure often used to gauge whether a stock looks expensive or cheap relative to its profits. Its dividend yield of +3.0% points to steady income paid out to shareholders, a feature that tends to appeal to those drawn to defensive, income-generating stocks rather than fast growth.
How to trade The Procter & Gamble Company
Shares like this are usually traded as CFDs. Compare regulated brokers that offer share CFDs — weigh spreads, fees and platforms before you open an account.
AI-assisted research for informational purposes only — not investment advice. Figures are sourced from third-party market data and may be delayed. Do your own research before trading. Your capital is at risk. How we build these pages.